|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 19/00 | |
| C07K 16/46 | |||
| C07K 14/72 |
| (11) | Patento numeris | 3020732 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14822721.8 |
| Europos patento paraiškos padavimo data | 2014-07-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-05-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-03-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/KR2014/006328 |
| Data | 2014-07-14 |
| (87) | Numeris | WO 2015/005747 |
| Data | 2015-01-15 |
| (30) | Numeris | Data | Šalis |
| 20130082509 | 2013-07-12 | KR |
| (72) |
HWANG, Sang Youn, KR
LEE, Jong Soo, KR
HONG, Sung Hee, KR
CHOI, In Young, KR
JUNG, Sung Youb, KR
KWON, Se Chang, KR
|
| (73) |
Hanmi Pharm. Co., Ltd.,
214 Muha-ro Paltan-myeon, Hwaseong-si, Gyeonggi-do 445-858,
KR
|
| (54) | AN IMMUNOGLOBULIN FC CONJUGATE WHICH MAINTAINS BINDING AFFINITY OF IMMUNOGLOBULIN FC FRAGMENT TO FCRN |
| AN IMMUNOGLOBULIN FC CONJUGATE WHICH MAINTAINS BINDING AFFINITY OF IMMUNOGLOBULIN FC FRAGMENT TO FCRN |